Mackenzie Financial Corp Illumina, Inc. Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

A detailed history of Mackenzie Financial Corp transactions in Illumina, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 19,355 shares of ILMN stock, worth $2.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,355

Previous 10,409 85.94%

Holding current value

$2.77 Million

Previous $1.09 Million 132.32%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$105.28 - $135.9 $941,834 - $1.22 Million	8,946 Added 85.94%	19,355 $2.52 Million
Q2 2024 Aug 14, 2024	SELL	$101.05 - $133.57 $429,866 - $568,206	-4,254 Reduced 29.01%	10,409 $1.09 Million
Q1 2024 May 10, 2024	BUY	$127.73 - $147.2 $72,550 - $83,609	568 Added 4.03%	14,663 $2.01 Million
Q4 2023 Jan 30, 2024	SELL	$92.79 - $142.53 $98,264 - $150,939	-1,059 Reduced 6.99%	14,095 $1.96 Million
Q3 2023 Oct 25, 2023	SELL	$128.91 - $192.44 $13,793 - $20,591	-107 Reduced 0.7%	15,154 $2.08 Million
Q2 2023 Aug 03, 2023	BUY	$183.43 - $232.67 $37,419 - $47,464	204 Added 1.35%	15,261 $2.86 Million
Q1 2023 Apr 24, 2023	SELL	$193.75 - $232.55 $71,687 - $86,043	-370 Reduced 2.4%	15,057 $3.5 Million
Q4 2022 Feb 14, 2023	BUY	$187.24 - $242.74 $140,804 - $182,540	752 Added 5.12%	15,427 $3.12 Million
Q3 2022 Oct 07, 2022	BUY	$177.23 - $227.44 $49,092 - $63,000	277 Added 1.92%	14,675 $2.8 Million
Q2 2022 Aug 10, 2022	BUY	$181.58 - $368.0 $114,032 - $231,104	628 Added 4.56%	14,398 $2.65 Million
Q1 2022 May 13, 2022	SELL	$303.87 - $423.8 $854,178 - $1.19 Million	-2,811 Reduced 16.95%	13,770 $4.81 Million
Q4 2021 Feb 14, 2022	BUY	$347.28 - $421.83 $41,673 - $50,619	120 Added 0.73%	16,581 $6.31 Million
Q3 2021 Nov 08, 2021	BUY	$405.61 - $524.84 $915,461 - $1.18 Million	2,257 Added 15.89%	16,461 $6.68 Million
Q2 2021 Aug 11, 2021	BUY	$372.84 - $481.5 $343,385 - $443,461	921 Added 6.93%	14,204 $6.72 Million
Q1 2021 May 14, 2021	BUY	$361.28 - $504.76 $1.98 Million - $2.76 Million	5,467 Added 69.95%	13,283 $5.1 Million
Q4 2020 Feb 10, 2021	BUY	$292.7 - $370.96 $146,350 - $185,480	500 Added 6.83%	7,816 $2.89 Million
Q3 2020 Nov 13, 2020	BUY	$268.51 - $400.74 $13,962 - $20,838	52 Added 0.72%	7,316 $2.26 Million
Q2 2020 Aug 13, 2020	BUY	$256.46 - $373.01 $420,594 - $611,736	1,640 Added 29.16%	7,264 $2.69 Million
Q1 2020 May 14, 2020	BUY	$209.2 - $335.53 $678,226 - $1.09 Million	3,242 Added 136.1%	5,624 $1.54 Million
Q4 2019 Feb 13, 2020	BUY	$288.29 - $335.49 $437,912 - $509,609	1,519 Added 176.01%	2,382 $790,000
Q3 2019 Nov 14, 2019	BUY	$266.84 - $378.23 $1,067 - $1,512	4 Added 0.47%	863 $263,000
Q2 2019 Aug 14, 2019	SELL	$300.59 - $368.15 $94,685 - $115,967	-315 Reduced 26.83%	859 $316,000
Q1 2019 May 15, 2019	SELL	$272.57 - $321.18 $12.1 Million - $14.2 Million	-44,252 Reduced 97.42%	1,174 $365,000
Q4 2018 Feb 06, 2019	BUY	$272.46 - $366.54 $11.3 Million - $15.2 Million	41,455 Added 1043.94%	45,426 $13.6 Million
Q3 2018 Nov 15, 2018	SELL	$279.04 - $367.06 $169,935 - $223,539	-609 Reduced 13.3%	3,971 $1.46 Million
Q2 2018 Aug 13, 2018	SELL	$228.17 - $292.07 $14,602 - $18,692	-64 Reduced 1.38%	4,580 $1.28 Million
Q1 2018 May 14, 2018	BUY	$209.54 - $253.91 $312,633 - $378,833	1,492 Added 47.34%	4,644 $1.1 Million
Q4 2017 Feb 13, 2018	BUY	$202.23 - $230.03 $330,646 - $376,099	1,635 Added 107.78%	3,152 $689,000
Q3 2017 Nov 13, 2017	BUY	$172.3 - $213.93 $33,081 - $41,074	192 Added 14.49%	1,517 $302,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,325	1,325 $230,000

Others Institutions Holding ILMN

# of Institutions

901

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Illumina, Inc. Transaction History